Inari Medical [NARI] vs Globus Medical [GMED] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Inari Medical Inc. wins in 2 metrics, Globus Medical Inc. wins in 14 metrics, with 0 ties. Globus Medical Inc. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Inari Medical Inc. | Globus Medical Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -2,665.67 | 23.94 | Globus Medical Inc. |
| Price-to-Book Ratio | 10.75 | 2.77 | Globus Medical Inc. |
| Debt-to-Equity Ratio | 7.53 | 2.61 | Globus Medical Inc. |
| PEG Ratio | 571.21 | 0.05 | Globus Medical Inc. |
| EV/EBITDA | -176.14 | 13.97 | Globus Medical Inc. |
| Profit Margin (TTM) | -13.68% | 18.30% | Globus Medical Inc. |
| Operating Margin (TTM) | -4.34% | 24.38% | Globus Medical Inc. |
| EBITDA Margin (TTM) | N/A | 24.38% | N/A |
| Return on Equity | -17.72% | 12.29% | Globus Medical Inc. |
| Return on Assets (TTM) | -3.21% | 7.11% | Globus Medical Inc. |
| Free Cash Flow (TTM) | N/A | $579.02M | N/A |
| 1-Year Return | N/A | 36.49% | N/A |
| Price-to-Sales Ratio (TTM) | 8.15 | 4.32 | Globus Medical Inc. |
| Enterprise Value | $4.60B | $12.25B | Globus Medical Inc. |
| EV/Revenue Ratio | 8.01 | 4.17 | Globus Medical Inc. |
| Gross Profit Margin (TTM) | 87.06% | 68.41% | Inari Medical Inc. |
| Revenue per Share (TTM) | $10 | $22 | Globus Medical Inc. |
| Earnings per Share (Diluted) | $-1.35 | $3.92 | Globus Medical Inc. |
| Beta (Stock Volatility) | 1.03 | 1.09 | Inari Medical Inc. |
| Short % of Float | N/A | 2.30% | N/A |
Inari Medical Inc. vs Globus Medical Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Inari Medical Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Globus Medical Inc. | -3.82% | -1.25% | 0.89% | -9.84% | -10.61% | -11.43% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Inari Medical Inc. | N/A | N/A | N/A | N/A | N/A | N/A |
| Globus Medical Inc. | 36.49% | 37.11% | 11.89% | 242.23% | 495.48% | 495.48% |
Performance & Financial Health Analysis: Inari Medical Inc. vs Globus Medical Inc.
| Metric | NARI | GMED |
|---|---|---|
| Market Information | ||
| Market Cap | $4.68B | $12.77B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 1,052,478 | 1,080,999 |
| 90 Day Avg. Volume | 3,170,369 | 1,058,813 |
| Last Close | $79.97 | $77.32 |
| 52 Week Range | $36.73 - $79.99 | $51.79 - $101.40 |
| % from 52W High | -0.02% | -23.75% |
| All-Time High | $79.97 (Feb 19, 2025) | $101.40 (Jan 08, 2026) |
| % from All-Time High | 0.00% | -23.75% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.21% | 0.26% |
| Quarterly Earnings Growth | N/A | 4.30% |
| Financial Health | ||
| Profit Margin (TTM) | -0.14% | 0.18% |
| Operating Margin (TTM) | -0.04% | 0.24% |
| Return on Equity (TTM) | -0.18% | 0.12% |
| Debt to Equity (MRQ) | 7.53 | 2.61 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $7.44 | $33.86 |
| Cash per Share (MRQ) | $1.91 | $4.12 |
| Operating Cash Flow (TTM) | $14.18M | $753.45M |
| Levered Free Cash Flow (TTM) | $86.61M | $327.53M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Inari Medical Inc. vs Globus Medical Inc.
| Metric | NARI (Mar 31, 2025) | GMED (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -2,665.67 | 23.94 |
| Forward P/E | 571.21 | 18.93 |
| PEG Ratio | 571.21 | 0.05 |
| Price to Sales (TTM) | 8.15 | 4.32 |
| Price to Book (MRQ) | 10.75 | 2.77 |
| Market Capitalization | ||
| Market Capitalization | $4.68B | $12.77B |
| Enterprise Value | $4.60B | $12.25B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 8.01 | 4.17 |
| Enterprise to EBITDA | -176.14 | 13.97 |
| Risk & Other Metrics | ||
| Beta | 1.03 | 1.09 |
| Book Value per Share (MRQ) | $7.44 | $33.86 |
Financial Statements Comparison: Inari Medical Inc. vs Globus Medical Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | NARI (2023) | GMED (2025) |
|---|---|---|
| Revenue/Sales | 493.63M | 2.94B |
| Cost of Goods Sold | 59.07M | 957.80M |
| COGS % of Revenue | 12.0% | 32.6% |
| Gross Profit | 434.56M | 1.98B |
| Gross Margin | 88.0% | 67.4% |
| Research & Development | 87.53M | 147.25M |
| Operating Income (EBIT) | -14.03M | 537.19M |
| Operating Margin | -2.8% | 18.3% |
| EBITDA | 15.18M | 756.71M |
| EBITDA Margin | 3.1% | 25.7% |
| Pre-Tax Income | 4.25M | 605.07M |
| Pre-Tax Income % of Revenue | 0.9% | 20.6% |
| Income Tax | 5.88M | 67.20M |
| Income Tax % of Revenue | 1.2% | 2.3% |
| Net Income (Profit) | -1.64M | 537.87M |
| Profit Margin | -0.3% | 18.3% |
Balance Sheet & Liquidity Metrics
| Metric | NARI (2023) | GMED (2025) |
|---|---|---|
| Cash & Equivalents | 38.60M | 526.16M |
| Total Current Assets | 235.56M | 2.13B |
| Total Current Assets % of Revenue | 47.7% | 72.3% |
| Total Current Liabilities | 76.34M | 498.50M |
| Total Current Liabilities % of Revenue | 15.5% | 17.0% |
| Long-Term Debt | 30.36M | 103.92M |
| Long-Term Debt % of Revenue | 6.1% | 3.5% |
| Total Shareholders Equity | 464.91M | 4.57B |
| Retained Earnings | -48.49M | 1.39B |
| Retained Earnings % of Revenue | -9.8% | 47.2% |
| Property, Plant & Equipment | 65.06M | 1.19B |
Cash Flow Statement Comparison
| Metric | NARI (2023) | GMED (2025) |
|---|---|---|
| Operating Cash Flow | N/A | 675.82M |
| Operating Cash Flow % of Revenue | 0.0% | 23.0% |
| Capital Expenditures | N/A | -164.68M |
| Free Cash Flow | N/A | 579.02M |
| FCF Margin | 0.0% | 19.7% |
| Debt Repayment | N/A | -449.99M |
| Common Stock Repurchase | N/A | -300.45M |
Short Interest & Institutional Ownership Analysis
| Metric | NARI | GMED |
|---|---|---|
| Shares Short | N/A | 2.83M |
| Short Ratio | N/A | 2.87 |
| Short % of Float | N/A | 2.30% |
| Shares Outstanding | 57.76M | 135.06M |
| Float Shares | 53.34M | 111.93M |
| % Held by Insiders | 9.00% | 0.67% |
| % Held by Institutions | 95.56% | 102.68% |
| % Held by Public | -4.56% | -3.35% |
Dividend Analysis & Yield Comparison: Inari Medical Inc. vs Globus Medical Inc.
| Metric | NARI | GMED |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |